MXCT vs TOST · rev $38.6M vs P/E 161, rev $4.96B
MaxCyte Inc (MXCT) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TOST revenue for 2024-12-31 was $4.96B. Net income was $19.0M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
MXCT currently screens at market cap $124.3M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the MXCT and TOST stock pages for the full models.
Not investment advice.